Alan Colman
Directeur/Membre du Conseil chez VOLITIONRX LIMITED
Fortune : 140 349 $ au 31/05/2024
Postes actifs de Alan Colman
Sociétés | Poste | Début | Fin |
---|---|---|---|
VOLITIONRX LIMITED | Directeur/Membre du Conseil | 06/10/2011 | - |
Independent Dir/Board Member | 06/10/2011 | - | |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
Volition America, Inc.
Volition America, Inc. Medical/Nursing ServicesHealth Services Volition America, Inc. is a company dedicated to advancing the science of epigenetics to revolutionize the diagnosis and monitoring of life-altering diseases. The company is based in Austin, TX. The company's ground-breaking diagnostic solution, ® nets, detects and monitors netosis. The company is committed to improving health outcomes worldwide through earlier disease diagnosis and monitoring. The CEOs of the company are Cameron John Reynolds and Gaetan Michel. | Directeur/Membre du Conseil | 06/10/2011 | - |
Independent Dir/Board Member | 06/10/2011 | - | |
Gaibian Associates Pte Ltd. | Directeur/Membre du Conseil | - | - |
Historique de carrière de Alan Colman
Anciens postes connus de Alan Colman
Sociétés | Poste | Début | Fin |
---|---|---|---|
Singapore Volition Pte Ltd.
Singapore Volition Pte Ltd. Hospital/Nursing ManagementHealth Services Part of VolitionRX Ltd., Singapore Volition Pte Ltd. provides diagnostic services for cancer patients. Singapore Volition was acquired by Standard Capital Corp. on October 07, 2011 for $0.07 million. | Directeur/Membre du Conseil | 01/04/2011 | 15/12/2015 |
The Singapore Stem Cell Consortium | Directeur/Membre du Conseil | 01/01/2006 | 01/01/2013 |
King's College London | Corporate Officer/Principal | 01/01/2008 | 01/01/2009 |
ES Cell International Pte Ltd.
ES Cell International Pte Ltd. BiotechnologyHealth Technology ES Cell International Pte Ltd. develops human embroyonic stem cell technologies for research and commercial applications. It develops an array of intellectual property in the fields of drug discovery, diagnostics, and therapeutics based on stem cell technology. The company was founded by Ariff Bongso, Robert Klupacs, Martin F. Pera, Reubinoff Benjamin and Alan Osborne Trounson in 2000 and is headquartered in Singapore. | Directeur Général | 01/01/2002 | 01/01/2007 |
PPL Therapeutics Plc
PPL Therapeutics Plc Pharmaceuticals: MajorHealth Technology PPL Therapeutics Plc produces commercially valuable proteins. It is a multinational corporation operating in the field of recombinant proteins using transgenic technology. The company does business in the pharmaceutical, biotechnology and nutraceutical industries. PPL is headquartered in Edinburgh, UK. | Directeur Technique/Scientifique/R&D | 01/01/1987 | 01/03/2002 |
░░░░░░░░░░ ░░ ░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Alan Colman
University of Oxford | Doctorate Degree |
University of Cambridge | Doctorate Degree |
Statistiques
Internationale
Royaume-Uni | 6 |
Singapour | 5 |
Etats-Unis | 4 |
Opérationnelle
Director/Board Member | 5 |
Corporate Officer/Principal | 3 |
Independent Dir/Board Member | 2 |
Sectorielle
Consumer Services | 6 |
Health Technology | 4 |
Health Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
VOLITIONRX LIMITED | Health Technology |
Entreprise privées | 6 |
---|---|
PPL Therapeutics Plc
PPL Therapeutics Plc Pharmaceuticals: MajorHealth Technology PPL Therapeutics Plc produces commercially valuable proteins. It is a multinational corporation operating in the field of recombinant proteins using transgenic technology. The company does business in the pharmaceutical, biotechnology and nutraceutical industries. PPL is headquartered in Edinburgh, UK. | Health Technology |
ES Cell International Pte Ltd.
ES Cell International Pte Ltd. BiotechnologyHealth Technology ES Cell International Pte Ltd. develops human embroyonic stem cell technologies for research and commercial applications. It develops an array of intellectual property in the fields of drug discovery, diagnostics, and therapeutics based on stem cell technology. The company was founded by Ariff Bongso, Robert Klupacs, Martin F. Pera, Reubinoff Benjamin and Alan Osborne Trounson in 2000 and is headquartered in Singapore. | Health Technology |
Singapore Volition Pte Ltd.
Singapore Volition Pte Ltd. Hospital/Nursing ManagementHealth Services Part of VolitionRX Ltd., Singapore Volition Pte Ltd. provides diagnostic services for cancer patients. Singapore Volition was acquired by Standard Capital Corp. on October 07, 2011 for $0.07 million. | Health Services |
The Singapore Stem Cell Consortium | |
Volition America, Inc.
Volition America, Inc. Medical/Nursing ServicesHealth Services Volition America, Inc. is a company dedicated to advancing the science of epigenetics to revolutionize the diagnosis and monitoring of life-altering diseases. The company is based in Austin, TX. The company's ground-breaking diagnostic solution, ® nets, detects and monitors netosis. The company is committed to improving health outcomes worldwide through earlier disease diagnosis and monitoring. The CEOs of the company are Cameron John Reynolds and Gaetan Michel. | Health Services |
Gaibian Associates Pte Ltd. |
- Bourse
- Insiders
- Alan Colman
- Expérience